SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear? -- Ignore unavailable to you. Want to Upgrade?

To: Cacaito who wrote (16507)12/4/2003 9:59:24 PM
From: Bluegreen  Read Replies (1) | Respond to of 17367
 
Cacaito I think the idea is to try to find uses for Neuprex ergo the study in pediatric heart surgery. Just think what work you could be doing with Neuprex in your arsenal. BTW, why don't YOU establish a probe study for Neuprex? Hey it wouldn't hurt the old curriculum vitae.



To: Cacaito who wrote (16507)12/20/2003 1:08:46 PM
From: Bluegreen  Respond to of 17367
 
Cacaito, why go ahead with CAB-2? Is there that much difference between Alxn molecule and this one??? I don't get it. Thanks in advance.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News